In recent years, pharmaceutical companies have expanded clinical research in emerging markets around the world and increasingly involving populations that traditionally have had limited or no access to clinical trials...Read more
Cara Cuenot
Lead counsel for the BioCorrection Research Unit, Pfizer Inc, USA
Cara Cuenot is lead counsel for the BioCorrection Research Unit at Pfizer. She also helps to support R&D policy related matters. She holds a BS from the University of Vermont, a JD / MS from Syracuse University and her MBE from the School of Medicine at the University of Pennsylvania.
